Skip to content

Efficacy of mannate sodium (GV-971) in the treatment of behavioral and psychological symptoms of in patients with mild to moderate Alzheimer's disease

Efficacy of mannate sodium (GV-971) in the treatment of behavioral and psychological symptoms of in patients with mild to moderate Alzheimer's disease

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500108873
Enrollment
Unknown
Registered
2025-09-08
Start date
2025-09-08
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimers disease

Interventions

Intervention group:Donepezil combined with mannitol treatment
Control group:Only accept Donepezil treatment

Sponsors

The Fourth People's Hospital of Chengdu
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for AD in ICD-10; 2. The severity of dementia is mild to moderate (MMSE: 10~26); 3. The patient has at least one psychobehavioral symptom; 4. Voluntary participation or participation in this study with the consent of family members.

Exclusion criteria

Exclusion criteria: 1. Exclude those with serious diseases of heart, liver, kidneys and other important organs; 2. Exclude other causes of dementia, such as vascular dementia, hypothyroidism, vitamin B or folic acid deficiency, niacin deficiency, hypocalcemia, neurosyphilis, HIV infection; 3. Exclude previous mental disorders such as depression, schizophrenia, etc.; 4. Exclude those who cannot complete the examination.

Design outcomes

Primary

MeasureTime frame
Neuropsychiatric Inventory(NPI);

Secondary

MeasureTime frame
Easy Intelligent Mental State;

Countries

China

Contacts

Public ContactXiance He

The Fourth People's Hospital of Chengdu

woaijixianger4@163.com+86 28 6951 5695

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026